BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially ...
Labcorp will start testing for monkeypox, doubling testing capacity nationwide. Labcorp will start testing for monkeypox, doubling testing capacity nationwide. Beginning Wednesday, Labcorp will test ...
BURLINGTON, North Carolina -- LabCorp has received emergency use authorization from the Food and Drug Administration for its Pixel at home coronavirus test kit. The COVID-19 At Home Test Kit allows ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Labcorp will begin testing for monkeypox using the CDC's ...
Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer MRD testing helps clinicians track a patient's risk ...
Developed in collaboration with Amazon Web Services, Test Finder is now available on Labcorp.com "Clinicians are under increasing pressure to do more with less," said Dr. Brian Caveney, Labcorp's ...
Stinging Insect Component Testing Combined with Interpretative Report Offers Enhanced Patient Management “Labcorp is the only reference laboratory to offer stinging insect (venom) component testing,” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results